OICR News / Tag

Steven Gallinger

Browse news tagged Steven Gallinger.

Browse all news

Filters

Discover the latest news and insightsDiscover the latest news and insights

All Collaboration Commercialization Talent Technology

All Video Article

Tagged stories

CollaborationClinical trials

“Dream team” science helps move Ontario ahead of the curve on hard-to-treat cancers

OICR’s Translational Research Initiatives (TRIs) made a lasting impact for patients. In 2017, ovarian cancer research was due for a new approach. Despite the best efforts of scientists, clinicians and patients, outcomes hadn’t improved for…

ArticleFeb 28, 2024

TalentDiagnosis

Ontario Institute for Cancer Research announces funding for sixteen studies that support early detection of cancer, the development of new diagnostics to guide therapy and improved treatment options for patients

Funding provides $16 million in support for Ontario cancer research December 2, 2021—Toronto—Today the Ontario Institute for Cancer Research (OICR) announced funding for 16 studies as part of the Institute’s new Clinical Translation Pathway (CTP).…

ArticleDec 02, 2021

Talent

OICR appoints Dr. Steven Gallinger as Head, Clinical Translation

Gallinger brings more than three decades of clinical and interdisciplinary research experience to OICR leadership Dr. Steven Gallinger has joined OICR’s executive leadership team as Head, Clinical Translation. In this role, he will lead one…

ArticleMar 18, 2021

TechnologyTreatment

OICR research leads to new pancreatic cancer clinical trial with aim to change the standard of care for patients

New pancreatic cancer trial, NeoPancONE, launches across Canada Adapted from Pancreatic Cancer Canada’s press release. OICR’s PanCuRx team and collaborators have launched NeoPancONE, a Phase II clinical trial that will evaluate a potentially curative treatment…

ArticleJul 24, 2020

CollaborationPancreatic cancer

Philanthropic donation moves The Alex U. Soyka Pancreatic Cancer Research Project: An International Partnership into Phase II

Ontario-Israel collaboration to explore personalized treatment and improved diagnostics for pancreatic cancer Toronto – (June 24, 2020) A second significant multi-year commitment from Sylvia M. G. Soyka, Director, and the Alex U. Soyka Foundation to…

ArticleJun 24, 2020

TechnologyTreatment

Unique Toronto-based clinical trial reveals new subtypes of advanced pancreatic cancer

Researchers identify five subtypes of pancreatic cancer, uncovering new opportunities for targeted treatment of the aggressive disease Toronto – (January 13, 2020) Researchers at the Ontario Institute for Cancer Research (OICR) and the University Health…

ArticleJan 13, 2020

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Steven Gallinger

Discover the latest news and insightsDiscover the latest news and insights

Tagged stories

“Dream team” science helps move Ontario ahead of the curve on hard-to-treat cancers

Ontario Institute for Cancer Research announces funding for sixteen studies that support early detection of cancer, the development of new diagnostics to guide therapy and improved treatment options for patients

OICR appoints Dr. Steven Gallinger as Head, Clinical Translation

Cancer solved together — in your inbox

OICR research leads to new pancreatic cancer clinical trial with aim to change the standard of care for patients

Philanthropic donation moves The Alex U. Soyka Pancreatic Cancer Research Project: An International Partnership into Phase II

Unique Toronto-based clinical trial reveals new subtypes of advanced pancreatic cancer